Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.52% |
| 2 | Healthcare | 7.46% |
| 3 | Financials | 6.74% |
| 4 | Industrials | 6.14% |
| 5 | Consumer Discretionary | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Axsome Therapeutics
AXSM
$11.2B
| $6.2M | ﹤0.01% |
33,937
+28,196
| +491% | +$3.94M |
|
2677
PUT
Cameco
CCJ
$37.6B
| $6.19M | ﹤0.01% |
67,700
+29,500
| +77% | +$2.66M |
|
2678
Freedom Holding
FRHC
$9.63B
| $6.19M | ﹤0.01% |
50,893
-70,611
| -58% | -$10.2M |
|
|
MICC
2679
The Magnum Ice Cream Company N.V.
MICC
$11.4B
| $6.19M | ﹤0.01% |
+390,636
| New | +$6.13M |
|
2680
CALL
Iron Mountain
IRM
$36.4B
| $6.19M | ﹤0.01% |
74,600
+39,300
| +111% | +$3.68M |
|
2681
New Oriental
EDU
$9.37B
| $6.17M | ﹤0.01% |
112,135
+43,166
| +63% | +$2.37M |
|
|
OS
2682
DELISTED
OneStream Inc
OS
| $6.17M | ﹤0.01% |
335,581
-368,195
| -52% | -$7.02M |
|
|
MOFG
2683
DELISTED
MidWestOne Financial Group
MOFG
| $6.17M | ﹤0.01% |
160,153
-37,369
| -19% | -$1.36M |
|
2684
Arthur J. Gallagher & Co
AJG
$64.1B
| $6.16M | ﹤0.01% |
23,788
-172,038
| -88% | -$45.5M |
|
2685
CALL
Parker-Hannifin
PH
$123B
| $6.15M | ﹤0.01% |
7,000
-14,200
| -67% | -$11.6M |
|
|
BLDP
2686
Ballard Power Systems
BLDP
$805M
| $6.14M | ﹤0.01% |
2,414,800
+350,395
| +17% | +$1.09M |
|
2687
Benchmark Electronics
BHE
$2.87B
| $6.14M | ﹤0.01% |
143,569
-197,888
| -58% | -$8.57M |
|
|
AII
2688
American Integrity Insurance
AII
$397M
| $6.14M | ﹤0.01% |
294,576
+265,867
| +926% | +$5.91M |
|
|
RAPP
2689
Rapport Therapeutics
RAPP
$1.96B
| $6.12M | ﹤0.01% |
201,825
+47,651
| +31% | +$1.32M |
|
2690
ENI
E
$80.5B
| $6.12M | ﹤0.01% |
161,359
-28,924
| -15% | -$1.06M |
|
|
TSSI
2691
TSS Inc
TSSI
$278M
| $6.12M | ﹤0.01% |
865,350
+489,497
| +130% | +$6.33M |
|
2692
Recursion Pharmaceuticals
RXRX
$1.59B
| $6.12M | ﹤0.01% |
+1,495,839
| New | +$7.41M |
|
2693
DiaMedica Therapeutics
DMAC
$342M
| $6.12M | ﹤0.01% |
768,560
-418,749
| -35% | -$3.13M |
|
2694
Atmus Filtration Technologies
ATMU
$4.22B
| $6.11M | ﹤0.01% |
117,797
-22,072
| -16% | -$1.07M |
|
2695
Old Second Bancorp
OSBC
$1.29B
| $6.11M | ﹤0.01% |
+313,560
| New | +$5.86M |
|
2696
Denali Therapeutics
DNLI
$3.65B
| $6.1M | ﹤0.01% |
369,767
-937,404
| -72% | -$15.8M |
|
2697
TriMas Corp
TRS
$1.43B
| $6.09M | ﹤0.01% |
171,719
+59,373
| +53% | +$2.07M |
|
2698
PUT
Abercrombie & Fitch
ANF
$4.42B
| $6.08M | ﹤0.01% |
48,300
-86,700
| -64% | -$7.58M |
|
2699
Acadia Healthcare
ACHC
$2.76B
| $6.08M | ﹤0.01% |
428,304
+180,787
| +73% | +$3.42M |
|
2700
Xometry
XMTR
$4.74B
| $6.08M | ﹤0.01% |
102,191
+68,721
| +205% | +$3.87M |
|
Similar funds
Millennium Management's Q4 2025 Portfolio in Review
As of Q4 2025, Millennium Management held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Millennium Management's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Millennium Management's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Millennium Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Millennium Management's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Millennium Management opened 668 new positions and closed 696 in Q4 2025.
- Millennium Management's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.